Tranexamic Acid Injection, Solution
NDC Package 23155-166-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tranexamic Acid injection is a medication used to treat heavy bleeding during your menstrual period. This formulation utilizes a injection, solution delivery system. Marketed by Heritage Pharmaceuticals Labs Inc. D/b/a Avet Pharmaceuticals Labs Inc., this product is identified by NDC 23155-166 and is authorized under FDA application ANDA203521.

Identification & Billing

NDC Package Code
23155-166-41
Package Description
10 VIAL, GLASS in 1 CARTON / 10 mL in 1 VIAL, GLASS (23155-166-31)
Product Code
23155-166
11-Digit Billing Format
23155016641
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tranexamic Acid
Non-Proprietary Name
Tranexamic Acid
Substance Name
Tranexamic Acid
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
TRANEXAMIC ACID 1 g/10mL
Pharmacologic Class
Usage Information
This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases.

Regulatory & Marketing

Labeler Name
Heritage Pharmaceuticals Labs Inc. D/b/a Avet Pharmaceuticals Labs Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA203521
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-13-2014
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 23155-166-41 identifies a specific commercial package of 10 vial, glass in 1 carton / 10 ml in 1 vial, glass (23155-166-31) of Tranexamic Acid, a human prescription drug labeled by Heritage Pharmaceuticals Labs Inc. D/b/a Avet Pharmaceuticals Labs Inc.. This injection, solution is formulated for intravenous use and contains tranexamic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Heritage Pharmaceuticals Labs Inc. D/b/a Avet Pharmaceuticals Labs Inc. on August 13, 2014. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases.

How is this Heritage Pharmaceuticals Labs Inc. D/b/a Avet Pharmaceuticals Labs Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 23155016641. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
23155-166-41
11-Digit CMS (5-4-2)
23155-0166-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.